Apr 04, 2013 15:36 CEST GE Healthcare Life Sciences at BPI Europe: Newsroom GE Healthcare Life Sciences’ acquisitions of PAA Laboratories and Xcellerex not only signalled the company’s intent in cell culture, it also demonstrated the industry’s general move, and need, for more integrated upstream and downstream processing.





